Cargando…

Association of Spike-Specific T Cells With Relative Protection From Subsequent SARS-CoV-2 Omicron Infection in Young Children

This cohort study investigates the risk of SARS-CoV-2 reinfection among young children with and without spike-specific T-cell responses.

Detalles Bibliográficos
Autores principales:	Dowell, Alexander C., Ireland, Georgina, Zuo, Jianmin, Moss, Paul, Ladhani, Shamez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593316/ https://www.ncbi.nlm.nih.gov/pubmed/36279118 http://dx.doi.org/10.1001/jamapediatrics.2022.3868

Ejemplares similares

Nucleocapsid-Specific Antibodies as a Correlate of Protection against SARS-CoV-2 Reinfection in Children
por: Dowell, Alexander C., et al.
Publicado: (2023)

Significantly lower infection fatality rates associated with SARS-CoV-2 Omicron (B.1.1.529) infection in children and young people: Active, prospective national surveillance, January-March 2022, England
por: Hani, Erjola, et al.
Publicado: (2023)

Experimental Infection of Mink with SARS-COV-2 Omicron Variant and Subsequent Clinical Disease
por: Virtanen, Jenni, et al.
Publicado: (2022)

Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
por: Dowell, Alexander C., et al.
Publicado: (2021)

Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study
por: Aiano, Felicity, et al.
Publicado: (2023)

Very low rates of severe COVID-19 in children hospitalised with confirmed SARS-CoV-2 infection in London, England”
por: Zsigmond, Borbàla, et al.
Publicado: (2022)

Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
por: Zuo, Jianmin, et al.
Publicado: (2021)

Structural diversity of the SARS-CoV-2 Omicron spike
por: Gobeil, Sophie M.-C., et al.
Publicado: (2022)

Immunological imprinting of humoral immunity to SARS-CoV-2 in children
por: Dowell, Alexander C., et al.
Publicado: (2023)

SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis
por: Zhang, Yanan, et al.
Publicado: (2022)

Surface electrostatic shift on spike protein decreased antibody activities against SARS-CoV-2 Omicron variant
por: Yuan, Shu, et al.
Publicado: (2022)

Using Spike Gene Target Failure to Estimate Growth Rate of the Alpha and Omicron Variants of SARS-CoV-2
por: Smith, Benjamin F., et al.
Publicado: (2022)

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
por: Havervall, Sebastian, et al.
Publicado: (2022)

An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant
por: Zhang, Hong-Qing, et al.
Publicado: (2022)

Cryo-EM structure of the SARS-CoV-2 Omicron spike
por: Cerutti, Gabriele, et al.
Publicado: (2022)

Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
por: Zuo, Jianmin, et al.
Publicado: (2021)

Spike protein of SARS‐CoV‐2 Omicron (B.1.1.529) variant has a reduced ability to induce the immune response
por: He, Cai, et al.
Publicado: (2022)

Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
por: Yamasoba, Daichi, et al.
Publicado: (2022)

Structural and functional impact by SARS-CoV-2 Omicron spike mutations
por: Zhang, Jun, et al.
Publicado: (2022)

T cell responses to SARS-CoV-2 spike cross-recognize Omicron
por: Keeton, Roanne, et al.
Publicado: (2022)

Omicron: A SARS‐CoV‐2 variant of real concern
por: Gattinger, Pia, et al.
Publicado: (2022)

CHANGES IN SARS-COV-2 ANTIBODY PREVALENCE IN PRIMARY AND SECONDARY SCHOOLS STUDENTS DURING THE EMERGENCE OF THE OMICRON VARIANT: THE UK SCHOOLS INFECTION SURVEYS
por: Nguipdop-Djomo, P., et al.
Publicado: (2023)

Peculiar Variations of the Electrostatic Potential of Spike Protein N-terminal Domain Associated with the Emergence of Successive SARS-CoV-2 Omicron Lineages
por: Pascarella, Stefano, et al.
Publicado: (2023)

New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March–May 2023
por: Mwanga, Mike J., et al.
Publicado: (2023)

Recombinant proteins of spike protein of SARS-CoV-2 with the Omicron receptor-binding domain induce production of highly Omicron-specific neutralizing antibodies
por: Kang, Hyangju, et al.
Publicado: (2022)

Disproportionate impact of SARS-CoV-2 on ethnic minority and frontline healthcare workers: A cross-sectional seroprevalence survey at a North London hospital
por: Martyn, Emily M., et al.
Publicado: (2021)

Molecular Evolutionary Analyses of the Spike Protein Gene and Spike Protein in the SARS-CoV-2 Omicron Subvariants
por: Nagasawa, Norika, et al.
Publicado: (2023)

Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes
por: Liu, Yang, et al.
Publicado: (2022)

Omicron: a chimera of two early SARS-CoV-2 lineages
por: Liu, Xiuliang, et al.
Publicado: (2022)

Evolutionary characteristics of SARS-CoV-2 Omicron subvariants adapted to the host
por: Tang, Haijun, et al.
Publicado: (2023)

Omicron variant in the current SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

Determinants of reinfection with SARS-CoV-2 Omicron variant
por: Bisharat, N., et al.
Publicado: (2023)

Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
por: Dimeglio, Chloé, et al.
Publicado: (2022)

SARS-CoV-2 Omicron spike mediated immune escape and tropism shift
por: Gupta, Ravindra
Publicado: (2022)

Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike
por: Stalls, Victoria, et al.
Publicado: (2022)

Protection from infection and reinfection due to the Omicron BA.1 variant in care homes
por: Choudhry, Saher, et al.
Publicado: (2023)

Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
por: Changrob, Siriruk, et al.
Publicado: (2023)

Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study
por: Powell, Annabel A, et al.
Publicado: (2023)

Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
por: Jimenez Ruiz, Jose A., et al.
Publicado: (2022)

Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemic
por: Rowland, Thomas A.J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mqi5795hveh5a4r4lqrsnq59ss